TGA have implemented the cybersecurity regulatory recommendations:
Australia’s Therapeutic Goods Administration (TGA) has implemented the final guidance on pre- and post-market cybersecurity regulatory recommendations for medical device, software and IVD manufacturers and sponsors. The TGA guidance applies to software as a medical device (SaMD) as well as medical devices and IVDs incorporating components that may be vulnerable to cyber threats. The TGA guidance aligns […]
Factsheet released by EC: prediction on possible failure of manufacturers in meeting compliance deadlines
European Commission advises a new factsheet for healthcare providers and institutions for healthcare providers and institutions to prepare for possible shortages of some medical devices and IVDs if the manufacturers do not meet compliance deadlines for the Medical Devices Regulation (MDR) and In-vitro Diagnostic Medical Devices Regulation (IVDR). The factsheet cites several issues pertaining to […]
Four organizations designated as UDI Issuing Agencies by EC
The European Commission has designated four organizations as Unique Device Identification (UDI) Issuing Agencies to support medical device and IVD manufacturers comply with new regulatory requirements applicable for Medical Devices under the Medical Devices Regulation (EU) 2017/745 (MDR) and In-Vitro Diagnostic Medical Devices (EU) 2017/746 (IVDR). These agencies will issue the unique codes necessary for […]
USFDA defines Test Plan for Digital Health Software Precertification (Pre-Cert) Program
The FDA is seeking test cases from software organizations planning to submit a De Novo Request or 510(k) submission for software as a medical device (SaMD) in 2019 or shortly thereafter to meet the goals of the Test Plan. The FDA’s request for test case submissions follows the rollout of the Pre-Cert program’s test plan earlier in 2019 establishing processes […]
Guidance on Unique Device Identification (UDI) system in Saudi Arabia
The Saudi Food and Drug Authority (SFDA) has issued guidance on establishing a Unique Device Identification (UDI) system in Saudi Arabia. The guidance covers all medical devices and accessories registered in Saudi Arabia, with the exception of custom-made devices as well as investigational medical devices and IVD devices. The UDI requirements listed by SFDA, generally in line […]
MHLW may extend participation in MDSAP through early 2020
The Japanese Ministry of Health, Labor and Welfare (MHLW) is extending the country’s participation in the Medical Device Single Audit Program through early 2020. According to a recent notification from the Japanese Pharmaceutical and Medical Devices Agency (PMDA), the decision to continue participation means MDSAP certificates will remain valid for Japanese quality management system requirements and audits […]
FDA finalizes Class I classification for some medical device accessories
The US Food and Drug Administration has published a final rule that will go into effect from May 13, 2019, it includes a finalized list of accessories to be designated as low-risk Class I medical devices in accordance with the FDA Reauthorization Act of 2017 (FDARA). FDA have considered an accessory to be eligible for […]
US FDA plans closer evaluations of certain materials used to manufacture medical devices
US medical device regulators are planning more focused evaluations of materials used in the manufacture of medical devices for safety issues. According to a US FDA announcement, the agency acknowledges that despite current safety measures in place for certain implantable devices, “more work needs to be done” to address inflammatory reactions and other health conditions some […]
FDA issues final guidance on medical devices containing animal or animal-derived materials
The US Food and Drug Administration (FDA) has issued final guidance on medical devices containing materials derived from animal sources on March 15, 2019.The guidance is intended to help medical device companies establish and document procedures that mitigate risk of infectious disease exposure through contact with devices containing animal-derived materials. In the final guidance, the recommendations for […]
US FDA proposes more transparent process for managing requests for feedback on Form 483 observations
The US Food and Drug Administration plans to formalize processes for managing feedback requests received from medical device companies cited for deficiencies following establishment inspections, helping firms to determine adequate responses and corrective actions. The new draft guidance from the agency would set up a standardized process through which companies that have received FDA Inspectional Observation Form […]
About Author
STARK BLOG
Add Short Descriptiop From Users > Your Profile > Biographical Info
